The reported sensitivity of TK1 as a tumour marker depends on the assay and corresponding cut‐off value (Table 1) and lies between 71% and 74% (Larsdotter et al., 2015; Wang et al., 2021). This evidence concerns the gene TK1 and neoplasm.